President Donald J. Trump nominated Scott Gottlieb, M.D., to serve as Commissioner of the U.S. Food and Drug Administration. Dr. Gottlieb served as the FDA’s Deputy Commissioner for Medical and Scientific Affairs in his most recent government role. He has served as a member of New Enterprise Associate’s healthcare investing team since leaving the FDA in 2007.

A frequent contributor to The Wall Street Journal, Dr. Gottlieb serves as a resident fellow at the American Enterprise Institute as an advisor to the National Coalition for Cancer Survivorship, and is a member of the policy board to the Society of Hospital Medicine. The U.S. Senate also appointed him to serve on the Federal Health IT Policy Committee. 

Related: US Senator Takes Aim at Dairy Alternatives with 'Dairy Pride Act'; Congressional Coalition Urges FDA to Police 'Misleading' Dairy Terms.